Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TT vs GSK✓SelectedUSD · GSKTT vs GSK performance historyLatest closeAs of-1.43%11/13
Stock and ETF performance explorer

TT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.5%
GSK return
+65.8%
Excess return
+25.6%
Maximum drawdown
-24.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%+0.5%-2.0%-1.5%
7D+4.0%+1.1%+2.9%+4.0%
30D-11.3%+6.3%-17.6%-11.6%
3M-12.3%+1.8%-14.1%-12.4%
6M-10.8%+1.7%-12.5%-11.0%
YTD+8.2%+6.5%+1.6%+8.0%
1Y+1.5%+9.5%-8.0%+1.1%
3Y+91.5%+65.3%+26.2%+81.9%
All+91.5%+65.8%+25.6%+81.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling